CN111004276B - 一种磷酰胺衍生物及其制备方法和催化应用 - Google Patents
一种磷酰胺衍生物及其制备方法和催化应用 Download PDFInfo
- Publication number
- CN111004276B CN111004276B CN201911193104.8A CN201911193104A CN111004276B CN 111004276 B CN111004276 B CN 111004276B CN 201911193104 A CN201911193104 A CN 201911193104A CN 111004276 B CN111004276 B CN 111004276B
- Authority
- CN
- China
- Prior art keywords
- reaction
- phosphoramide
- aryl
- allyl alcohol
- rearrangement reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 230000003197 catalytic effect Effects 0.000 title abstract description 8
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical class CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 title description 7
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000006462 rearrangement reaction Methods 0.000 claims abstract description 22
- -1 phosphamide compound Chemical class 0.000 claims abstract description 18
- 125000003118 aryl group Chemical group 0.000 claims abstract description 16
- 150000008039 phosphoramides Chemical class 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 14
- 150000002576 ketones Chemical class 0.000 claims abstract description 13
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 11
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims description 49
- 239000003054 catalyst Substances 0.000 claims description 17
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 12
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 6
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims description 5
- 125000006736 (C6-C20) aryl group Chemical group 0.000 claims description 5
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims description 5
- 125000005865 C2-C10alkynyl group Chemical group 0.000 claims description 5
- 235000010290 biphenyl Nutrition 0.000 claims description 5
- 239000004305 biphenyl Substances 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 5
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 150000004808 allyl alcohols Chemical class 0.000 claims description 3
- 230000008707 rearrangement Effects 0.000 claims description 2
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000005561 phenanthryl group Chemical group 0.000 claims 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 abstract description 32
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract description 17
- 238000003786 synthesis reaction Methods 0.000 abstract description 13
- 230000015572 biosynthetic process Effects 0.000 abstract description 9
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 abstract description 8
- 125000000217 alkyl group Chemical group 0.000 abstract description 5
- 238000005580 one pot reaction Methods 0.000 abstract description 5
- 125000003342 alkenyl group Chemical group 0.000 abstract description 4
- 125000000304 alkynyl group Chemical group 0.000 abstract description 4
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003960 organic solvent Substances 0.000 abstract description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 36
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 25
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 24
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 229910052757 nitrogen Inorganic materials 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- HNVRRHSXBLFLIG-UHFFFAOYSA-N 3-hydroxy-3-methylbut-1-ene Chemical compound CC(C)(O)C=C HNVRRHSXBLFLIG-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 10
- 239000012295 chemical reaction liquid Substances 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- YOWQWFMSQCOSBA-UHFFFAOYSA-N 2-methoxypropene Chemical compound COC(C)=C YOWQWFMSQCOSBA-UHFFFAOYSA-N 0.000 description 9
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 8
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 8
- JPTOCTSNXXKSSN-UHFFFAOYSA-N methylheptenone Chemical compound CCCC=CC(=O)CC JPTOCTSNXXKSSN-UHFFFAOYSA-N 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 229940124530 sulfonamide Drugs 0.000 description 8
- 150000003456 sulfonamides Chemical class 0.000 description 8
- BZAZNULYLRVMSW-UHFFFAOYSA-N 2-Methyl-2-buten-3-ol Natural products CC(C)=C(C)O BZAZNULYLRVMSW-UHFFFAOYSA-N 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 7
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 6
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 6
- 229930007744 linalool Natural products 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 5
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 5
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 238000002390 rotary evaporation Methods 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- FSGHEPDRMHVUCQ-UHFFFAOYSA-N 2-ethoxyprop-1-ene Chemical compound CCOC(C)=C FSGHEPDRMHVUCQ-UHFFFAOYSA-N 0.000 description 4
- RGUKYNXWOWSRET-UHFFFAOYSA-N 4-pyrrolidin-1-ylpyridine Chemical compound C1CCCN1C1=CC=NC=C1 RGUKYNXWOWSRET-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- MOFVJGYEQJCCFN-UHFFFAOYSA-N n-diaminophosphorylmethanesulfonamide Chemical compound CS(=O)(=O)NP(N)(N)=O MOFVJGYEQJCCFN-UHFFFAOYSA-N 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZCRZCMUDOWDGOB-UHFFFAOYSA-N ethanesulfonimidic acid Chemical compound CCS(N)(=O)=O ZCRZCMUDOWDGOB-UHFFFAOYSA-N 0.000 description 3
- 239000012847 fine chemical Substances 0.000 description 3
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 3
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- MNOJRWOWILAHAV-UHFFFAOYSA-N 3-bromophenol Chemical compound OC1=CC=CC(Br)=C1 MNOJRWOWILAHAV-UHFFFAOYSA-N 0.000 description 2
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- LTUMRKDLVGQMJU-UHFFFAOYSA-N famesylacetone Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=O LTUMRKDLVGQMJU-UHFFFAOYSA-N 0.000 description 2
- LTUMRKDLVGQMJU-IUBLYSDUSA-N farnesyl acetone Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CCC(C)=O LTUMRKDLVGQMJU-IUBLYSDUSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- HNZUNIKWNYHEJJ-FMIVXFBMSA-N geranyl acetone Chemical compound CC(C)=CCC\C(C)=C\CCC(C)=O HNZUNIKWNYHEJJ-FMIVXFBMSA-N 0.000 description 2
- HNZUNIKWNYHEJJ-UHFFFAOYSA-N geranyl acetone Natural products CC(C)=CCCC(C)=CCCC(C)=O HNZUNIKWNYHEJJ-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- MUVQKFGNPGZBII-UHFFFAOYSA-N 1-anthrol Chemical compound C1=CC=C2C=C3C(O)=CC=CC3=CC2=C1 MUVQKFGNPGZBII-UHFFFAOYSA-N 0.000 description 1
- DVWQNBIUTWDZMW-UHFFFAOYSA-N 1-naphthalen-1-ylnaphthalen-2-ol Chemical compound C1=CC=C2C(C3=C4C=CC=CC4=CC=C3O)=CC=CC2=C1 DVWQNBIUTWDZMW-UHFFFAOYSA-N 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 150000004786 2-naphthols Chemical class 0.000 description 1
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- 239000007848 Bronsted acid Substances 0.000 description 1
- NAXRQLBSHOSVLM-UHFFFAOYSA-N C1=CC=C(C=C1)C(CS(=O)(=O)NP(=O)(O)O)C2=CC=CC=C2 Chemical compound C1=CC=C(C=C1)C(CS(=O)(=O)NP(=O)(O)O)C2=CC=CC=C2 NAXRQLBSHOSVLM-UHFFFAOYSA-N 0.000 description 1
- REELAHGHHDOKEX-UHFFFAOYSA-N CC1=CC=C(C=C1)ONP(=O)(NOC2=CC=C(C=C2)C)NS(=O)(=O)C Chemical compound CC1=CC=C(C=C1)ONP(=O)(NOC2=CC=C(C=C2)C)NS(=O)(=O)C REELAHGHHDOKEX-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- UHZFCCQSJAHOFE-UHFFFAOYSA-N N-diaminophosphorylethanesulfonamide Chemical compound CCS(=O)(=O)NP(N)(N)=O UHZFCCQSJAHOFE-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001336 alkenes Chemical group 0.000 description 1
- 150000001345 alkine derivatives Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical group 0.000 description 1
- 229950011260 betanaphthol Drugs 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 1
- 235000019838 diammonium phosphate Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- KPYFOUXOECJJGC-UHFFFAOYSA-N n-diaminophosphoryl-4-methylbenzenesulfonamide Chemical compound CC1=CC=C(S(=O)(=O)NP(N)(N)=O)C=C1 KPYFOUXOECJJGC-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- ZYMJSAWYDBRZIC-UHFFFAOYSA-N oxalic acid phosphoric acid Chemical class OP(O)(O)=O.OC(=O)C(O)=O.OC(=O)C(O)=O.OC(=O)C(O)=O ZYMJSAWYDBRZIC-UHFFFAOYSA-N 0.000 description 1
- UMLDYULSMQUBPR-UHFFFAOYSA-N oxalic acid;phosphoric acid Chemical class OP(O)(O)=O.OC(=O)C(O)=O.OC(=O)C(O)=O UMLDYULSMQUBPR-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2479—Compounds containing the structure P(=X)n-N-acyl, P(=X)n-N-heteroatom, P(=X)n-N-CN (X = O, S, Se; n = 0, 1)
- C07F9/2483—Compounds containing the structure P(=X)n-N-acyl, P(=X)n-N-heteroatom, P(=X)n-N-CN (X = O, S, Se; n = 0, 1) containing the structure P(=X)n-N-S (X = O, S, Se; n = 0, 1)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
- B01J31/0271—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds also containing elements or functional groups covered by B01J31/0201 - B01J31/0231
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
- C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2404—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/242—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyaryl compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域
本发明属于精细化工和香精香料领域,具体涉及一种磷酰胺衍生物及其一锅法快速高效制备方法,以及所得磷酰胺衍生物在重排反应中的催化应用。
背景技术
γ,δ-不饱和酮广泛地存在天然产物和精细化学品中,例如甲基庚烯酮,具有清新的水果香气,是一种国标允许使用的食用香精,同时甲基庚烯酮还是重要的合成中间体,可以用于合成芳樟醇、乙酸芳樟酯、维生素A和维生素Ε等具有很大经济价值的精细化学品。香叶基丙酮、金合欢基丙酮等也是典型的γ,δ-不饱和酮,也有非常重要的应用。
早在1967年,Saucy等人就发现在催化量的磷酸存在下,烯丙基醇和2-烷氧基丙烯在120-200℃反应12-16小时,可以高产率的得到γ,δ-不饱和酮;但是当产物是甲基庚烯酮时,收率仅有41%(Helv.Chim.Acta.1967,50,2091-2095.)。后来人们发现许多其他的酸性催化剂也可以催化该反应。
专利CN1914143A发现氢化三(草酸)磷酸盐或氢化双(草酸)磷酸盐可以有效的催化2-甲基-3-丁烯-2-醇和2-烷氧基丙烯重排反应,高收率得到甲基庚烯酮;催化剂用量为2-甲基-3-丁烯-2-醇的0.15mol%,在150℃下反应24小时能得到90%以上的收率。专利CN102197014A采用氯化铵、溴化铵或者磷酸氢二铵催化烯丙醇和2-乙氧基丙烯反应,优点是避免了酸性条件的使用,反应收率较高,但是反应时间很长,一般需要12~40小时。专利WO2018091623A1采用有机磷酸,如2-苄氧基磷酸、联苯二酚磷酸等,催化烯丙醇和异丙烯基烷基醚重排反应,反应温度120-150℃,反应压力8-12bar,以优良的收率得到γ,δ-不饱和酮产物。专利CN106478514A以布朗斯特酸功能化离子液体为催化剂,实现了烯丙基醇和2-烷氧基丙烯的重排反应,得到较好的收率。
综上所述,虽然目前已经有多种催化剂被应用与烯丙醇和2-烷氧基丙烯重排反应中,但是这些催化剂的活性一般较差,需要较高的反应温度、较长的反应时间才能完成反应。鉴于γ,δ-不饱和酮产物的重要性,目前需要发展新型的催化剂,能具有较高的催化活性,能在较为温和的反应条件下、较短的时间内完成催化反应,提高装置的时空收率,更加高效、快速地得到甲基庚烯酮为代表的γ,δ-不饱和酮产品。
发明内容
本发明的目的在于提供一种磷酰胺衍生物及其一锅法快速高效合成的方法,以及所得磷酰胺衍生物在重排反应中的催化应用,特别是烯丙醇和烷氧基丙烯之间的重排反应。
根据本发明的第一个方面,提供一种磷酰胺衍生物,其结构式如下:
其中,R1各自独立地选自芳基和杂芳基,例如C6-C30芳基和C5-C30杂芳基,例如苯基、联苯基、取代苯基、萘基、蒽基、菲基或者其他更高碳数的芳环和芳杂环取代基,R2选自烷基、烯基、炔基、芳基和杂芳基,例如C1-C20烷基、C2-C10烯基、C2-C10炔基、C6-C20芳基例如苯基、取代苯基、C5-C20杂芳基取代基。
根据本发明的第二个方面,提供了上述磷酰胺的制备方法,包括如下步骤:在催化剂和碱试剂的存在下让三氯氧磷、酚和磺酰胺反应。
进一步地,磺酰胺采用如下通式的磺酰胺:
R2SO2NH2
R2选自烷基、烯基、炔基、芳基和杂芳基,例如C1-C20烷基、C2-C10烯基、C2-C10炔基、C6-C20芳基例如苯基、取代苯基、C5-C20杂芳基取代基。
本发明采用如下技术方案:三氯氧磷、酚、磺酰胺在催化剂和碱作用下,一步反应得到磷酰胺衍生物。
反应路线如下所示:
其中,R1各自独立地选自芳基和杂芳基,例如C6-C30芳基和C5-C30杂芳基,例如苯基、联苯基、取代苯基、萘基、蒽基、菲基或者其他更高碳数的芳环和芳杂环取代基,R2选自烷基、烯基、炔基、芳基和杂芳基,例如C1-C20烷基、C2-C10烯基、C2-C10炔基、C6-C20芳基例如苯基、取代苯基、C5-C20杂芳基取代基。
进一步地,按摩尔量计,酚的用量为三氯氧磷的1.5~2.5倍,优选2.0~2.05倍,磺酰胺的用量为三氯氧磷的0.8-1.5倍,优选1.0~1.05倍。
进一步地,所述磷酰胺衍生物由三氯氧磷、酚和磺酰胺一锅法制备而成;所述酚可以是苯酚、萘酚、蒽酚、2,2’-联萘酚或者其他更高碳数的芳环和芳杂环取代基的酚中的一种或多种;所述磺酰胺可以是甲磺酰胺、乙磺酰胺、苯磺酰胺、对甲苯磺酰胺或者更高碳数的烷基、烯烃、炔烃、芳烃取代的磺酰胺中的一种或多种。
进一步地,所述磷酰胺合成反应的催化剂是吡啶、4-甲基吡啶、4-二甲氨基吡啶、4-吡咯烷吡啶中的一种或多种,优选4-二甲氨基吡啶;催化剂用量为三氯氧磷摩尔量的1.0~10.0mol%,优选1.0~5.0mol%。
进一步地,所述磷酰胺合成反应在碱试剂的存在下进行,所述碱试剂是氢氧化锂、氢氧化钠、氢氧化钾、甲醇钠、乙醇钠、叔丁醇钾、氢化钠、氢化钾、氢化钙、三乙胺、二异丙基乙基胺中的一种或多种,优选三乙胺和二异丙基乙基胺,碱的用量为三氯氧磷摩尔量的600~900mol%,优选600~700mol%。
进一步地,所述磷酰胺合成反应在极性非质子型溶剂中进行,所述溶剂选自四氢呋喃、N,N-二甲基甲酰胺、二氯甲烷、二氯乙烷、乙腈中的一种或多种,优选为二氯乙烷。溶剂的用量可以是三氯氧磷、酚和磺酰胺的总质量的1-15倍。
进一步地,所述磷酰胺合成反应的温度为室温~80℃,反应压力为常压,反应时间4~10小时;优选的,氮气氛围中,室温下依次加入4-二甲氨基吡啶、二氯乙烷、三乙胺和三氯氧磷,快速搅拌下,滴加酚,室温反应1-3小时(例如约2小时)后,加入磺酰胺,然后在80±5℃回流反应2-4小时。
根据本发明的第三个方面,提供了上述磷酰胺衍生物作为催化剂的用途。
进一步地,上述磷酰胺衍生物应用于催化烯丙醇类化合物和2-烷氧基丙烯的重排反应而得到γ,δ-不饱和酮产物的催化剂。烯丙醇类化合物例如选自2-甲基-3-丁烯-2-醇、芳樟醇、橙花叔醇等。
根据所述的方法制备的磷酰胺衍生物,可以作为有机强酸催化反应,优选的,其用于催化以烯丙醇类化合物和2-烷氧基丙烯的重排反应,得到γ,δ-不饱和酮产物。
本发明中,所述磷酰胺催化的重排反应中可以是间歇的,也可以是连续的。
本发明因此还提供了一种由烯丙醇类化合物和2-烷氧基丙烯的重排反应制备γ,δ-不饱和酮产物的方法,其特征在于,使用上述磷酰胺衍生物作为催化剂,所述重排反应中,磷酰胺衍生物的用量为烯丙醇类化合物底物摩尔量的0.01~1.0mol%,优选0.1~0.5mol%,2-烷氧基丙烯的用量为烯丙醇类化合物底物摩尔量的200-500mol%,优选300-400mol%;和/或所述重排反应在无溶剂条件下进行。
本发明中,所述重排反应的反应温度为70~150℃,优选90~100℃;反应时间1~3小时;和/或反应压力为微正压。
本发明采用上述技术方案,具有如下积极效果:
1、原料三氯氧磷、酚、磺酰胺简单易得,价格低廉;以三者为原料,本发明采用一锅法一步合成磷酰胺衍生物,简化了操作,提高了合成收率;
2、所得磷酰胺化合物在有机溶剂中有良好的溶解性,同时又有强酸性,能高效催化烯丙醇和2-烷氧基丙烯之间的重排反应,催化剂用量少,反应条件温和,高收率得到γ,δ-不饱和酮产物。
具体实施方式
下面通过实施例详述本发明,但本发明并不限于下述的实施例。
主要原料信息如下:
苯酚、对甲酚、对甲氧基苯酚、3-溴苯酚、2-萘酚,上海迈瑞尔,99%;
三氯氧磷、三乙胺、二异丙基乙基胺,阿拉订试剂,99%;甲磺酰胺、乙磺酰胺、对甲苯磺酰胺,安耐吉试剂,99%
4-二甲氨基吡啶、4-吡咯烷基吡啶、2-甲氧基丙烯、2-乙氧基丙烯,Sigma-Aldrich,99%;
丙酮、二氯乙烷,安耐吉化学,色谱纯;2-甲基-3-丁烯-2醇、芳樟醇、橙花叔醇,自制,纯度>99.5%。
本发明的气相色谱测试条件如下:
仪器型号:Agilent GC;色谱柱:Agilent DB-5(30m×0.25mm×0.25μm);柱温:起始温度60℃,以3℃/min升温至70℃,然后以10℃/min升温100℃,最后以12℃/min升温至200℃,保持6min;进样口温度:280℃;FID检测器温度:300℃;分流进样,分流比40:1;进样量:1.0μL;H2流量:40mL/min;空气流量:360mL/min。
实施例1:
二苯氧基甲磺酰基磷酰胺合成(diphenyl methylsulfonylphosphoramidate)
氮气中,室温下依次向250mL三口瓶中加入4-二甲氨基吡啶(0.18g,1.5mmol)、二氯乙烷(40mL)、三乙胺(30.36g,0.3mol)和三氯氧磷(7.67g,0.05mol),开启搅拌,将三口瓶放入常温水浴,然后缓慢滴加苯酚(9.41g,0.1mol)的二氯乙烷(20mL)溶液,滴加完毕,继续室温搅拌反应2小时。最后滴加甲磺酰胺(4.76g,0.05mol)的二氯乙烷(20mL)溶液,滴加完毕,撤去水浴,将三口瓶放入油浴,加热回流2小时至反应完全。后处理,将反应液降至室温,加水淬灭反应,分相,有机相用4M盐酸洗涤2~3次,除去反应液中的4-二甲氨基吡啶和三乙胺,最后食盐水洗涤,无水硫酸钠干燥,过滤,旋转蒸发除去溶剂,得粗产物,采用二氯甲烷和乙醚混合溶剂结晶得到纯净的二苯氧基甲磺酰基磷酰胺14.25g,收率87.1%。1H-NMR(400MHz,CDCl3):δ7.18-7.28(m,10H),2.95(s,3H);13C-NMR(100MHz,CDCl3):150.2(2C),120.3(4C),130.1(4C),121.3(2C),46.6(1C);ESI-MS:C13H15NO5PS([M+H+])328.04。
实施例2:
二苯氧基乙磺酰基磷酰胺合成(diphenyl ethylsulfonylphosphoramidate)
氮气中,室温下依次向250mL三口瓶中加入4-吡咯烷基吡啶(0.37g,2.5mmol)、二氯乙烷(40mL)、三乙胺(30.36g,0.3mol)和三氯氧磷(7.67g,0.05mol),开启搅拌,将三口瓶放入常温水浴,然后缓慢滴加苯酚(9.65g,0.1025mol)的二氯乙烷(20mL)溶液,滴加完毕,继续室温搅拌反应2小时。最后滴加乙磺酰胺(5.46g,0.05mol)的二氯乙烷(20mL)溶液,滴加完毕,撤去水浴,将三口瓶放入油浴,加热回流2小时至反应完全。后处理,将反应液降至室温,加水淬灭反应,分相,有机相用4M盐酸洗涤2~3次,除去反应液中的4-吡咯烷基吡啶和三乙胺,最后食盐水洗涤,无水硫酸钠干燥,过滤,旋转蒸发除去溶剂,得粗产物,采用二氯甲烷和乙醚混合溶剂结晶得到纯净的二苯氧基乙磺酰基磷酰胺14.57g,收率85.4%。1H-NMR(400MHz,CDCl3):δ7.18-7.28(m,10H),3.45(q,J=8.0Hz,2H),1.22(t,J=8.0Hz 3H);13C-NMR(100MHz,CDCl3):150.2(2C),120.3(4C),130.1(4C),121.3(2C),54.6(1C),2.0(1C);ESI-MS:C14H17NO5PS([M+H+])342.05。
实施例3:
二苯氧基对甲苯磺酰基磷酰胺合成(diphenyl tosylphosphoramidate)
氮气中,室温下依次向250mL三口瓶中加入4-二甲氨基吡啶(0.18g,1.5mmol)、二氯乙烷(40mL)、二异丙基乙基胺(45.24g,0.35mol)和三氯氧磷(7.67g,0.05mol),开启搅拌,将三口瓶放入常温水浴,然后缓慢滴加苯酚(9.41g,0.1mol)的二氯乙烷(20mL)溶液,滴加完毕,继续室温搅拌反应2小时。最后滴加对甲苯磺酰胺(8.56g,0.05mol)的二氯乙烷(20mL)溶液,滴加完毕,撤去水浴,将三口瓶放入油浴,加热回流2小时至反应完全。后处理,将反应液降至室温,加水淬灭反应,分相,有机相用4M盐酸洗涤2~3次,除去反应液中的4-二甲氨基吡啶和二异丙基乙基胺,最后食盐水洗涤,无水硫酸钠干燥,过滤,旋转蒸发除去溶剂,得粗产物,采用二氯甲烷和乙醚混合溶剂结晶得到纯净的二苯氧基甲磺酰基磷酰胺16.84g,收率83.5%。1H-NMR(400MHz,CDCl3):δ7.40-7.78(dd,4H),7.18-7.28(m,10H),2.34(s,3H);13C-NMR(100MHz,CDCl3):150.2(2C),137.6(1C),136.7(1C),129.3(2C),128.3(2C),130.1(4C),121.3(2C),120.3(4C),21.3(1C);ESI-MS:C19H19NO5PS([M+H+])404.07。
实施例4:
二苯氧基甲磺酰基磷酰胺合成(diphenyl methylsulfonylphosphoramidate)
氮气中,室温下依次向250mL三口瓶中加入4-二甲氨基吡啶(0.18g,1.5mmol)、二氯乙烷(40mL)、三乙胺(30.36g,0.3mol)和三氯氧磷(7.67g,0.05mol),开启搅拌,将三口瓶放入常温水浴,然后缓慢滴加苯酚(7.06g,0.075mol)的二氯乙烷(20mL)溶液,滴加完毕,继续室温搅拌反应2小时。最后滴加甲磺酰胺(3.82g,0.04mol)的二氯乙烷(20mL)溶液,滴加完毕,撤去水浴,将三口瓶放入油浴,加热回流2小时至反应完全。后处理,将反应液降至室温,加水淬灭反应,分相,有机相用4M盐酸洗涤2~3次,除去反应液中的4-二甲氨基吡啶和三乙胺,最后食盐水洗涤,无水硫酸钠干燥,过滤,旋转蒸发除去溶剂,得粗产物,采用二氯甲烷和乙醚混合溶剂结晶得到纯净的二苯氧基甲磺酰基磷酰胺12.81g,收率78.3%。1H-NMR(400MHz,CDCl3):δ7.18-7.28(m,10H),2.95(s,3H);13C-NMR(100MHz,CDCl3):150.2(2C),120.3(4C),130.1(4C),121.3(2C),46.6(1C);ESI-MS:C13H15NO5PS([M+H+])328.04。
实施例5~8:
芳环氧基对甲磺酰基磷酰胺合成(di-aryl methylsulfonylphosphoramidate)
氮气中,室温下依次向250mL三口瓶中加入4-二甲氨基吡啶(0.18g,1.5mmol)、二氯乙烷(40mL)、三乙胺(30.36g,0.3mol)和三氯氧磷(7.67g,0.05mol),开启搅拌,将三口瓶放入常温水浴,然后缓慢滴加酚(0.1mol)的二氯乙烷(20mL)溶液,滴加完毕,继续室温搅拌反应2小时。最后滴加甲磺酰胺(4.76g,0.05mol)的二氯乙烷(20mL)溶液,滴加完毕,撤去水浴,将三口瓶放入油浴,加热回流2小时至反应完全。后处理,将反应液降至室温,加水淬灭反应,分相,有机相用4M盐酸洗涤2~3次,除去反应液中的4-二甲氨基吡啶和三乙胺,最后食盐水洗涤,无水硫酸钠干燥,过滤,旋转蒸发除去溶剂,得粗产物,采用二氯甲烷和乙醚混合溶剂结晶得到纯净的二芳基氧基甲磺酰基磷酰胺,具体合成收率请见下表。
实施例5~8反应结果
编号 | 酚 | 产品质量/g | 收率/% |
实施例5 | 对甲基苯酚 | 15.33 | 86.3 |
实施例6 | 对甲氧基苯酚 | 14.74 | 76.1 |
实施例7 | 间溴苯酚 | 22.24 | 91.7 |
实施例8 | 2-萘酚 | 18.34 | 85.8 |
上述制备的芳环氧基对甲磺酰基磷酰胺的表征结果如下:
实施例5:1H-NMR(400MHz,CDCl3):δ6.78-6.94(m,8H),5.35(s,2H),2.95(s,3H);13C-NMR(100MHz,CDCl3):151.2(2C),142.8(2C),117.3(8C),46.6(1C);ESI-MS:C13H15NO7PS([M+H+])360.03。
实施例6:1H-NMR(400MHz,CDCl3):δ6.78-6.82(m,8H),3.83(s,6H),2.94(s,3H);13C-NMR(100MHz,CDCl3):153.2(2C),142.5(2C),116.9(4C),115.7(4C),55.8(2C),46.7(1C);ESI-MS:C15H19NO7PS([M+H+])388.06。
实施例7:1H-NMR(400MHz,CDCl3):δ7.14-7.21(m,8H),2.94(s,3H);13C-NMR(100MHz,CDCl3):152.4(2C),131.3(2C),124.2(2C),123.3(2C),119.3(4C),46.6(1C);ESI-MS:C13H13Br2NO5PS([M+H+])486.85。
实施例8:1H-NMR(400MHz,CDCl3):δ7.16-7.98(m,14H),2.96(s,3H);13C-NMR(100MHz,CDCl3):153.2(2C),134.7(2C),129.9(2C),129.1(2C),127.8(2C),126.7(2C),126.4(2C),123.8(2C),117.6(2C),109.5(2C),46.6(1C);ESI-MS:C21H19NO5PS([M+H+])428.07。
实施例9:
二苯氧基甲磺酰基磷酰胺催化2-甲基-3-丁烯-2-醇和2-甲氧基丙烯反应
空气中,室温下向500mL高压釜中加入2-甲基-3-丁烯-2-醇(17.23g,0.2mmol)和2-甲氧基丙烯(43.26g,0.6mol),密封高压釜,高压釜内空气小心缓慢的用氮气置换三次,最后保持釜内氮气压力2.0MPa。开启高压釜搅拌(400rpm)和伴热,当反应釜的内温达到90℃时,用平流泵将二苯氧基甲磺酰基磷酰胺(65mg,0.2mmol)的丙酮溶液(2.0mL)缓慢打入到高压釜内,同时开始计时,保温反应2小时后,取样分析,GC检测,原料2-甲基-3-丁烯-2-醇转化率>99.5%,产物甲基庚烯酮的选择性93.1%。
实施例10:
二苯氧基三氟甲磺酰基磷酰胺催化2-甲基-3-丁烯-2-醇和2-甲氧基丙烯反应
空气中,室温下向500mL高压釜中加入2-甲基-3-丁烯-2-醇(17.23g,0.2mmol)和2-甲氧基丙烯(57.68g,0.8mol),密封高压釜,高压釜内空气小心缓慢的用氮气置换三次,最后保持釜内氮气压力2.0MPa。开启高压釜搅拌(600rpm)和伴热,当反应釜的内温达到70℃时,用平流泵将二苯氧基甲磺酰基磷酰胺(65mg,0.2mmol)的丙酮溶液(2.0mL)缓慢打入到高压釜内,同时开始计时,保温反应2小时后,取样分析,GC检测,原料2-甲基-3-丁烯-2-醇转化率>99.5%,产物甲基庚烯酮的选择性96.5%。
实施例11:
二苯氧基三氟对甲苯磺酰基磷酰胺催化2-甲基-3-丁烯-2-醇和2-甲氧基丙烯反应
空气中,室温下向500mL高压釜中加入2-甲基-3-丁烯-2-醇(17.23g,0.2mmol)和2-甲氧基丙烯(43.26g,0.6mol),密封高压釜,高压釜内空气小心缓慢的用氮气置换三次,最后保持釜内氮气压力2.0MPa。开启高压釜搅拌(400rpm)和伴热,当反应釜的内温达到110℃时,用平流泵将二苯氧基对甲苯磺酰基磷酰胺(403mg,1.0mmol)的丙酮溶液(10.0mL)缓慢打入到高压釜内,同时开始计时,保温反应3小时后,取样分析,GC检测,原料2-甲基-3-丁烯-2-醇转化率>99.5%,产物甲基庚烯酮的选择性91.7%。
实施例12:
二苯氧基甲磺酰基磷酰胺催化芳樟醇和2-乙氧基丙烯反应
空气中,室温下向500mL高压釜中加入芳樟醇(30.85g,0.2mmol)和2-乙氧基丙烯(51.68g,0.6mol),密封高压釜,高压釜内空气小心缓慢的用氮气置换三次,最后保持釜内氮气压力2.0MPa。开启高压釜搅拌(400rpm)和伴热,当反应釜的内温达到90℃时,用平流泵将二苯氧基甲磺酰基磷酰胺(65mg,0.2mmol)的丙酮溶液(4.0mL)缓慢打入到高压釜内,同时开始计时,保温反应2小时后,取样分析,GC检测,原料芳樟醇转化率>99.5%,产物香叶基丙酮的选择性96.9%。
实施例13:
二对甲苯氧基甲磺酰基磷酰胺催化橙花叔醇和2-甲氧基丙烯反应
空气中,室温下向500mL高压釜中加入橙花叔醇(44.47g,0.2mmol)和2-甲氧基丙烯(50.47g,0.7mol),密封高压釜,高压釜内空气小心缓慢的用氮气置换三次,最后保持釜内氮气压力1.5MPa。开启高压釜搅拌(400rpm)和伴热,当反应釜的内温达到100℃时,用平流泵将二苯氧基甲磺酰基磷酰胺(213mg,0.6mmol)的丙酮溶液(8.0mL)缓慢打入到高压釜内,同时开始计时,保温反应3小时后,取样分析,GC检测,原料橙花叔醇转化率>99.5%,产物金合欢基丙酮的选择性96.9%。
Claims (7)
2.根据权利要求1所述的用途,其中,R1各自独立地选自苯基、联苯基、萘基、蒽基、菲基。
4.根据权利要求3所述的方法,其中,R1各自独立地选自苯基、联苯基、萘基、蒽基、菲基。
5.根据权利要求3所述的方法,其中,重排反应中,磷酰胺衍生物的用量为烯丙醇类化合物底物摩尔量的0.1~0.5 mol%,2-烷氧基丙烯的用量为烯丙醇类化合物底物摩尔量的300-400 mol%。
6.根据权利要求3所述的方法,其中,所述重排反应在无溶剂条件下进行。
7.根据权利要求3所述的方法,其中,重排反应的反应温度为70~150℃,反应时间1~3小时;和/或
反应压力为微正压。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911193104.8A CN111004276B (zh) | 2019-11-28 | 2019-11-28 | 一种磷酰胺衍生物及其制备方法和催化应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911193104.8A CN111004276B (zh) | 2019-11-28 | 2019-11-28 | 一种磷酰胺衍生物及其制备方法和催化应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111004276A CN111004276A (zh) | 2020-04-14 |
CN111004276B true CN111004276B (zh) | 2023-01-13 |
Family
ID=70112345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911193104.8A Active CN111004276B (zh) | 2019-11-28 | 2019-11-28 | 一种磷酰胺衍生物及其制备方法和催化应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111004276B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112517062B (zh) * | 2020-12-14 | 2022-08-05 | 万华化学集团股份有限公司 | 一种磁性纳米粒子固载的磷酰胺酯催化剂及其制备方法及γ,δ-不饱和酮的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108530279A (zh) * | 2018-05-21 | 2018-09-14 | 浙江新和成股份有限公司 | 一种假性紫罗兰酮的合成方法 |
WO2018190304A1 (ja) * | 2017-04-10 | 2018-10-18 | セントラル硝子株式会社 | ホスホリルイミド塩の製造方法、該塩を含む非水電解液の製造方法及び非水二次電池の製造方法 |
JP2018177670A (ja) * | 2017-04-10 | 2018-11-15 | セントラル硝子株式会社 | 非対称イミド三級アンモニウム塩の製造方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009086303A2 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
-
2019
- 2019-11-28 CN CN201911193104.8A patent/CN111004276B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018190304A1 (ja) * | 2017-04-10 | 2018-10-18 | セントラル硝子株式会社 | ホスホリルイミド塩の製造方法、該塩を含む非水電解液の製造方法及び非水二次電池の製造方法 |
JP2018177670A (ja) * | 2017-04-10 | 2018-11-15 | セントラル硝子株式会社 | 非対称イミド三級アンモニウム塩の製造方法 |
CN108530279A (zh) * | 2018-05-21 | 2018-09-14 | 浙江新和成股份有限公司 | 一种假性紫罗兰酮的合成方法 |
Non-Patent Citations (2)
Title |
---|
Acylation of alkali salts of arenesulfonamides with phenyl phosphate and phenyl p-toluenesulfonate;Dubina, V. L et al.;《Ukrainskii Khimicheskii Zhurnal》;19671231;第719-720页 * |
Triaryloxyphosphazosulfonalkyls and aromatic esters of alkylsulfonamidophosphoric acids;Kirsanov, A. V et al.;《Zhurnal Obshchei Khimii》;19581231;第1052-1055页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111004276A (zh) | 2020-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ni et al. | Synthesis of new C2‐symmetrical bissulfonamide ligands and application in the enantioselective addition of alkynylzinc to aldehydes and ketones | |
CN107226779B (zh) | 用于使取代二烯烃选择性钯催化为调聚物的方法 | |
Yilmaz | Palladium (II) complexes with new bidentate phosphine-imine ligands for the Suzuki CC coupling reactions in supercritical carbon dioxide | |
Fornalczyk et al. | Enantioselective Reformatsky reaction of ethyl iododifluoroacetate with ketones | |
CN111333680B (zh) | 一种膦配体其制备方法及应用 | |
CN111004276B (zh) | 一种磷酰胺衍生物及其制备方法和催化应用 | |
CN102491862A (zh) | 一种纯水中制备联芳类化合物的方法 | |
WO2021195751A1 (en) | Catalytic cannabigerol processes and precursors | |
CN113387876A (zh) | 一种镍催化的杂环鏻盐与芳基溴的直接还原交叉偶联方法及产物 | |
Shimizu et al. | Water‐soluble calixarenes as new inverse phase‐transfer catalysts. Their scope in aqueous biphasic alkylations and mechanistic implications | |
CN105688987A (zh) | 一种新型的手性磷酸催化剂及其合成方法与应用 | |
CN111072605B (zh) | 一种氟烷基取代的苯并呋喃衍生物或吲哚衍生物的制备方法 | |
CN102249871B (zh) | 番茄红素中间体2,6,10-三甲基-1,1-二烷氧基-3,5,9-十一烷三烯的制备方法 | |
Paradisi et al. | Anion activation in the synthesis of ethers from oxygen anions and p-chloronitrobenzene | |
CN111892572B (zh) | 一种西瓜酮前体的合成工艺 | |
JP2013519519A (ja) | ブタジエンの短鎖重合に有用なホスフィンに基づく新規触媒 | |
CN113416138A (zh) | 一种铁介导醛与溴代硝基甲烷的Henry型反应方法及产物 | |
CN111087343B (zh) | 一种羟基吡啶配体及其制备方法和催化应用 | |
CN117321041A (zh) | 催化性大麻酚合成以及前体 | |
CN110590621A (zh) | 一种铜催化端炔合成1,2-双(芳基磺酰基)乙烯衍生物的方法 | |
CN109651194B (zh) | 一种(e)-4-芳基-3-丁烯腈化合物的合成方法 | |
CN110869340B (zh) | 生产3,7-二甲基-9-(2,6,6-三甲基-1-环己烯-1-基)-壬-2e,7e-二烯-4-炔-1,6-二醇的方法 | |
CN116143833A (zh) | 一种磷酰亚胺催化剂的制备方法及该催化剂在Saucy-Marbet重排反应中的应用 | |
CN102311320B (zh) | 一种2,6,10-三甲基-1,1-二烷氧基-3,5,9-十一烷三烯的制备方法 | |
El Houssame et al. | Palladium (0)-catalyzed allylic substitution of optically active natural terpenic functionalized olefins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |